Free Online CME
take the web survey

Published: March 2012

Eating Disorders

Kathleen N. Franco

Print this Content

Definition and Etiology

Eating disorders are syndromes characterized by significant disturbances in eating behavior and by distress or excessive concern about body shape or weight. Presentation varies, but eating disorders often occur with severe medical or psychiatric comorbidity. Denial of symptoms and reluctance to openly discuss make treatment especially challenging.

Back to Top

Classification

Major eating disorders can be classified as anorexia nervosa (Box 1), bulimia nervosa (Box 2), and eating disorder not otherwise specified (Box 3). Although criteria of the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM IV-TR), allow diagnosis of a specific eating disorder, many patients demonstrate a mixture of both anorexia and bulimia. Up to 50% of patients with anorexia nervosa develop bulimic symptoms, and a smaller percentage of patients who are initially bulimic develop anorexic symptoms.2

Box 1: DSM IV-TR Criteria for Anorexia Nervosa
Criteria
  • Refusal to maintain body weight at or above a minimally normal weight for age and height: Weight loss leading to maintenance of body weight <85% of that expected or failure to make expected weight gain during period of growth, leading to body weight less than 85% of that expected.
  • Intense fear of gaining weight or becoming fat, even though under weight.
  • Disturbance in the way one's body weight or shape are experienced, undue influence of body weight or shape on self evaluation, or denial of the seriousness of the current low body weight.
  • Amenorrhea (at least three consecutive cycles) in postmenarchal girls and women. Amenorrhea is defined as periods occurring only following hormone (e.g., estrogen) administration.
Type
  • Restricting type: During the current episode of anorexia nervosa, the person has not regularly engaged in binge-eating or purging behavior (self-induced vomiting or misuse of laxatives, diuretics, or enemas).
  • Binge-eating–purging type: During the current episode of anorexia nervosa, the person has regularly engaged in binge-eating or purging behavior (self-induced vomiting or the misuse of laxatives, diuretics, or enemas).

Adapted from American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text rev. Washington, DC, American Psychiatric Association, 2000.
See also Box 3.

Box 2: DSM IV-TR Criteria for Bulimia Nervosa
Criteria
  • Recurrent episodes of binge eating characterized by both:
    1. Eating, in a discrete period of time (e.g., within any 2-hour period), an amount of food that is definitely larger than most people would eat during a similar period of time and under similar circumstances
    2. A sense of lack of control over eating during the episode, defined by a feeling that one cannot stop eating or control what or how much one is eating
  • Recurrent inappropriate compensatory behavior to prevent weight gain
    1. Self-induced vomiting
    2. Misuse of laxatives, diuretics, enemas, or other medications
    3. Fasting
    4. Excessive exercise
  • The binge eating and inappropriate compensatory behavior both occur, on average, at least twice a week for 3 months.
  • Self evaluation is unduly influenced by body shape and weight.
  • The disturbance does not occur exclusively during episodes of anorexia nervosa.
Type
  • Purging type: During the current episode of bulimia nervosa, the person has regularly engaged in self-induced vomiting or the misuse of laxatives, diuretics, or enemas.
  • Nonpurging type: During the current episode of bulimia nervosa, the person has used inappropriate compensatory behavior but has not regularly engaged in self-induced vomiting or misused laxatives, diuretics, or enemas.

Adapted from American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text rev. Washington, DC, American Psychiatric Association, 2000.
See also Box 3.

Box 3: DSM IV-TR Criteria for Eating Disorder Not Otherwise Specified
Eating disorder not otherwise specified includes disorders of eating that do not meet the criteria for any specific eating disorder.
  1. For female patients, all of the criteria for anorexia nervosa are met except that the patient has regular menses.
  2. All of the criteria for anorexia nervosa are met except that, despite significant weight loss, the patient's current weight is in the normal range.
  3. All of the criteria for bulimia nervosa are met except that the binge eating and inappropriate compensatory mechanisms occur less than twice a week or for less than 3 months.
  4. The patient has normal body weight and regularly uses inappropriate compensatory behavior after eating small amounts of food (e.g., self-induced vomiting after consuming two cookies).
  5. Repeatedly chewing and spitting out, but not swallowing, large amounts of food.
Binge-eating disorder is recurrent episodes of binge eating in the absence if regular inappropriate compensatory behavior characteristic of bulimia nervosa.

Adapted from American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text rev. Washington, DC, American Psychiatric Association, 2000.
See also Boxes 1 and 2.

Anorexia nervosa has two subtypes: restrictive eating and binge eating alternating with restrictive eating at different periods of the illness. Patients with bulimia nervosa can be subclassified into purging and nonpurging. Many patients have a combination of eating disorder symptoms that cannot be strictly categorized as either anorexia nervosa or bulimia nervosa and are technically diagnosed as eating disorder not otherwise specified. Obesity alone is not considered an eating disorder.

Listed in the DSM IV-TR appendix, binge eating disorder is defined as uncontrolled binge eating without emesis or laxative abuse. It is often, but not always, associated with obesity symptoms. Night eating syndrome includes morning anorexia, increased appetite in the evening, and insomnia. Often obese, these patients can have complete or partial amnesia for eating during the night. There are overlaps in anorexia nervosa and other specific eating disorder diagnoses with eating disorder not otherwise specified.3

Eating disorders before puberty include food avoidance emotional disorder, which is similar to anorexia; selective eating of only a few foods; pervasive refusal syndrome, with reduced intake and added behavioral problems; and functional dysphagia with no organic etiology. Unpleasant mealtimes and conflicts over eating can precede these conditions of childhood. Pica and rumination are not considered eating disorders, but rather are feeding disorders of infancy and childhood.

Back to Top

Risk Factors and Prevalence

Eating disorders have been reported in up to 4% of adolescents and young adults. The most common age at onset for anorexia nervosa is the mid teens; in 5% of the patients, the onset of the disorder is in the early twenties. The onset of bulimia nervosa is usually in adolescence but may be as late as early adulthood.2, 4 Methodology differs and makes it challenging to pinpoint, but it is generally believed the eating disorders have grown over the past 50 years.5

Gender Prevalence

Both anorexia nervosa and bulimia nervosa are more commonly seen in girls and women. Estimates of female-to-male ratio range from 6 : 1 to 10 : 1.

Lifetime Prevalence

The reported lifetime prevalence of anorexia nervosa among women has ranged from 0.9% - 2.2% and 0.2 – 0.3% in men (Keski-R et al 2008).6 With regard to bulimia nervosa, estimates of lifetime prevalence among women range from 1.5% to 2% and 0.5% in men. Prevalence of eating disorders in young children is unknown. However, children as young as 5 years have reported awareness of dieting and know that inducing vomiting can produce weight loss. Eating disorder not otherwise specified is the most prevalent eating disorder. The National Comorbidity Survey Replication reported Binge Eating Disorders in 3.5% of women and 2% of men. Of patients requesting treatment for obesity, 5% - 10% may have binge eating disorders.7

Cultural Considerations

Eating disorders are more common in industrialized societies where there is an abundance of food and being thin, especially for women, is considered attractive.4 Eating disorders are most common in the United States, Canada, Europe, Australia, New Zealand, and South Africa. However, the prevalence in non-Western countries is growing.8 Rates are increasing in Asia, especially in Japan and China, where women are exposed to cultural change and modernization. In the United States, eating disorders are common in young Latin American, Native American, and African American women, but the rates are still lower than in white women. African American women are more likely to develop bulimia and more likely to purge. Female athletes involved in running, gymnastics, or ballet and male body builders or wrestlers are at increased risk.

Back to Top

Pathophysiology and Natural History

Biologic and psychosocial factors are implicated in the pathophysiology, but the causes and mechanisms underlying eating disorders remain uncertain.2, 4 More about environmental and genetic risk has recently has been uncovered and is leading to greater understanding.9, 10

Biologic Factors

First-degree female relatives and monozygotic twin offspring of patients with anorexia nervosa have higher rates of anorexia nervosa and bulimia nervosa. Children of patients with anorexia nervosa have a lifetime risk for anorexia nervosa that is tenfold that of the general population (5%). Families of patients with bulimia nervosa have higher rates of substance abuse, particularly alcoholism, affective disorders, and obesity. Traits such as impulsivity, negative affect, perfectionism, and low self esteem are risk factors that may largely be genetically determined.11 Treasure describes an emotional phenotype in which fear-anxiety and reward system distortions are operating.12

Endogenous opioids might contribute to denial of hunger in patients with anorexia nervosa. Some hypothesize that dieting can increase the risk for developing an eating disorder. Increased endorphin levels have been described in patients with bulimia nervosa after purging and may be likely to induce feelings of well being. Diminished norepinephrine turnover and activity are suggested by reduced levels of 3-methoxy-4-hydroxyphenylglycol in the urine and cerebrospinal fluid of some patients with anorexia nervosa. Antidepressants often benefit patients with bulimia nervosa and support a pathophysiologic role for serotonin and norepinephrine.

Starvation results in many biochemical changes such as hypercortisolemia, nonsuppression of dexamethasone, suppression of thyroid function, and amenorrhea. Several computed tomography (CT) studies of the brain have revealed enlarged sulci and ventricles, a finding that is reversed with weight gain. In one study using positron emission tomography (PET), metabolism was higher in the caudate nucleus during the anorectic state than after hyperalimentation.

Anorexia risk may increase with a polymorphism of the promoter region of serotonin 2a receptor. Monteleone and Maj reported not only that specific receptor but also the brain derived neurotrophic factor gene to be associated with restrictive type anorexia nervosa.11 The melancortin 4 receptor gene is hypothesized to regulate weight and appetite. Polymorphism in the gene for agouti-related peptide might also play a role at the melancortin receptor. In bulimia nervosa there is excessive secretion of ghrelin. Ghrelin receptor gene polymorphism is associated with both hyperphagia of bulimia and Prader-Willi syndrome.

Perhaps some of the most fascinating new research addresses the overlap between uncontrolled compulsive eating and compulsive drug seeking in drug addiction.13, 14 Reduction in ventral striatal dopamine is found in both of these groups. The lower the frequency of dopamine D2 receptors, the higher the body mass index. Obese persons might eat to temporarily increase activity in these reward circuits. Frequent visual food stimuli paired with increased sensitivity of right orbitofrontal brain activity is likely to initiate eating behavior. Marijuana’s well-known appetite stimulant effect is likely due to its agonist activity at cannabinoid receptors, and cannabinoid receptor antagonism has been associated with reduced binge eating (Fig. 1).

Psychosocial Factors

Anorexia may be a reaction to demands on adolescents to behave more independently or to respond to societal pressures to be slender. Movies, magazines, and other media show excessively slim starlets and models creating an unhealthy image of what young women should look like. This adds to the internal pressure for perfectionism. Anorexia nervosa patients are usually high achievers, and two thirds live at home with parents. Some consider their bodies to be under the control of their parents. Family dynamics alone, however, do not cause anorexia nervosa. Self starvation may be an effort to gain validation as a unique person. Patients with bulimia nervosa have been described as having difficulties with impulse regulation.

Course and Prognosis

As a general guideline, it appears that one third of patients fully recover, one third retain subthreshold symptoms, and one third maintain a chronic eating disorder. Sadly, mortality from anorexia nervosa in particular remains a great concern.15

Anorexia Nervosa

Long-term follow-up shows recovery rates ranging from 44% to 76%, with prolonged recovery time (57 to 59 months). Mortality (up to 20%) is primarily from cardiac arrest or suicide. Good prognostic factors are admission of hunger, lessening of denial, and improved self esteem. Poorer prognostic factors are initial lower minimum weight, presence of vomiting or laxative abuse, failure to respond to previous treatment, disturbed family relationships, and conflicts with parents.

Bulimia Nervosa

Little long-term follow-up data exist. Short-term success is 50% to 70%, with relapse rates between 30% and 50% after 6 months. These patients have an overall better prognosis as compared with anorexia nervosa patients. Poor prognostic factors are hospitalization, higher frequency of vomiting, poor social and occupational functioning, poor motivation for recovery, severity of purging, presence of medical complications, high levels of impulsivity, longer duration of illness, delayed treatment, and premorbid history of obesity and substance abuse.

Back to Top

Signs and Symptoms

Anorexia Nervosa

The essential features of anorexia nervosa are refusal to maintain a minimally normal body weight, intense fear of gaining weight, and significant disturbance in the perception of the shape or size of one’s body. Patients commonly lack insight into the problem and are brought to professional attention by a family member. DSM IV-TR identifies two subtypes of anorexia nervosa: restricting type and binge eating–purging type. Comorbid psychiatric symptoms include depressive symptoms such as depressed mood, social withdrawal, irritability, insomnia, and decreased sexual interest. Many depressive features may be secondary to the physiologic sequelae of semistarvation. Symptoms of mood disturbances need to be reassessed after partial or complete weight restoration. Obsessive-compulsive features—thoughts of food, hoarding food, picking or pulling apart small portions of food, or collecting recipes—are common. Anxiety symptoms and concerns of eating in public are also common.

Bulimia Nervosa

The essential features are binge eating and inappropriate compensatory behavior such as fasting, vomiting, using laxatives, or exercising to prevent weight gain. Binge eating is typically triggered by dysphoric mood states, interpersonal stressors, intense hunger following dietary restraints, or negative feelings related to body weight, shape, and food. Patients are typically ashamed of their eating problems, and binge eating usually occurs in secrecy. Unlike anorexia nervosa, bulimia nervosa patients are typically within normal weight range and restrict their total caloric consumption between binges.

Back to Top

Diagnosis

Rating Instruments

In addition to the clinical interview, the Eating Attitudes Test, Eating Disorders Inventory, Body Shape Questionnaire, and others can be used to assess eating disorders.16

Comorbidities and Coexisting Conditions with Eating Disorders

Psychiatric

Common comorbid conditions include major depressive disorder or dysthymia (50% to 75%), sexual abuse (20% to 50%), obsessive-compulsive disorder (25% with anorexia nervosa), substance abuse (12% to 18% with anorexia nervosa, especially the binge–purge subtype, and 30% to 37% with bulimia nervosa), and bipolar disorder (4% to 13%).17, 18

Medical

There are many complications related to weight loss, purging and vomiting, and laxative abuse (Box 4). When obesity is associated with the eating disorder, hyperlipidemia, diabetes mellitus, sleep apnea, joint injury, hypertension, and cardiac and respiratory disorders can result.19, 20, 21 Liver damage, headaches, and others are not infrequent.22, 23 Patients with infertility or who are pregnant should also be screened for eating disorders as treatment and management will be greatly impacted.24, 25 The role of obstetric complications, along with dysmaturity may actually impact vulnerability to later eating disorders.26 Cardiac complications and osteoporosis may result from anorexia nervosa and require intervention.27, 28

Box 4: Medical Complications of Eating Disorders
Weight Loss
  • Amenorrhea
  • Bradycardia
  • Cold intolerance
  • Constipation
  • Cyanosis
  • Edema
  • Hypoglycemia
  • Low albumin
  • Orthostatic blood pressure drop
  • Osteoporosis, stress fractures
  • Structural and functional brain changes
  • Thyroid dysfunction
Appetite Suppressant Abuse
  • Anxiety
  • Hypertension
  • Tachyarrhythmia
  • Tremors
Purging (Abuse of Laxatives, Ipecac, or Diuretics)
  • Abnormal colonic motility
  • Arrhythmias
  • Cardiac and other myopathies
  • Dehydration
  • Dental caries
  • Electrolyte abnormalities
  • Gastrointestinal irritation, bleeding, or reflux
  • Parotid abnormalities
  • Secondary renal failure

Back to Top

Differential Diagnosis

Anorexia Nervosa

Medical illnesses include brain tumors and other malignancies, gastrointestinal disease, and acquired immunodeficiency syndrome (AIDS).

Other psychiatric disorders with disturbed appetite or food intake include depression, somatization disorder, and schizophrenia. Patients with depressive disorder generally do not have an intense fear of obesity or body image disturbance. Depressed patients usually have a decreased appetite, whereas anorexia nervosa patients claim to have a normal appetite and to feel hungry. Patients with somatization disorder do not generally express a morbid fear of obesity. Severe weight loss and amenorrhea of more than 3 months are unusual in somatization disorder. Schizophrenic patients might have delusions about food being poisoned but rarely are they concerned with caloric content. They also do not express a fear of gaining weight. Bulimia nervosa patients usually maintain their weight within a normal range.

Bulimia Nervosa

General medical conditions of central nervous system pathology, such as brain tumors, can simulate bulimia nervosa. Kluver-Bucy syndrome is a rare condition characterized by hyperphagia, hypersexuality, and compulsive licking and biting. Klein-Levin syndrome, also rare, is more common in men and consists of hyperphagia and periodic hypersomnia.

Patients with the binge–purge subtype of anorexia nervosa fail to maintain their weight within a normal range. Patients with borderline personality disorder sometimes binge eat but do not have other criteria for bulimia nervosa.

Back to Top

Treatment

A comprehensive treatment plan including a combination of nutritional rehabilitation, psychotherapy, and medication is recommended (see Fig. 1).29 The patient’s weight and cardiac and metabolic status determines the acuteness of the illness and the need for hospitalization (Box 5). Treatment guidelines are well documented by the American Psychiatric Association in its practice guideline for treating eating disorders.29

Box 5: Indications for Hospitalization
Weight <75% of individually estimated healthy weight
Rapid, persistent decline in oral intake or weight despite maximally intensive outpatient interventions
Prior knowledge of weight at which physical instability is likely to occur in the particular patient
Serious physical abnormalities
  1. Electrolyte or metabolic abnormalities
  2. Hematemesis
  3. Vital sign changes including orthostatic hypotension and heart rate <40 bpm or >110 bpm
  4. Inability to sustain body core temperature
Comorbid psychiatric illness (suicidal, depressed, unable to care for self, etc.)

Aims of treatment are to restore the patient’s nutritional status and establish healthy eating patterns, treat medical complications, correct core dysfunctional thoughts related to the eating disorder, enlist family support, and provide family counseling. Transdiagnostic Cognitive Behavior can be tailored to a specific patient’s eating disorder.30 A broad form also addresses comorbidities, while the focused form resembles cognitive behavioural therapy as described later in this report.

Nutritional Rehabilitation

Expected rates of controlled weight gain should be 2 to 3 pounds per week for inpatients and 0.5 to 1 pound per week for outpatients. Intake levels should start at 30 to 40 kcal/kg per day (1000-1600 kcal/day) in divided meals. If oral feeding is not possible, progressive nocturnal nasogastric feeding can lessen distress (physical and psychological) during early weight gain.

Daily morning weights, vital signs, fluid intake, and urine output should be measured. Frequent physical examinations should be performed to detect circulatory overload, refeeding edema, and bloating. Monitor serum electrolyte levels (low potassium or phosphorus), and get an electrocardiogram if needed.

Stool softeners, not laxatives, should be used to treat constipation. The diet should be supplemented with vitamins and minerals.

Patients should be given positive reinforcement (praise) and negative reinforcement (restrictions of exercise and purging). They should be closely supervised, and access to bathrooms should be restricted for at least 2 hours after meals. After weight restoration has progressed, stretching can begin, followed by gradual reintroduction of aerobic exercise.

Psychosocial Treatment

Psychosocial treatments are required during hospitalization as well as after discharge.6-9 Commonly used models include dynamic expressive-supportive therapy and cognitive-behavioral techniques (planned meals and self-monitoring, exposure, and response pre¬vention). Research data more strongly support the efficacy of cognitive-behavioral and interpersonal therapies. Although cognitive-behavioral therapy is important, its benefits increase with the addition of a nutritional component. Cognitive Behavioral Therapy has proved superior to treatments for behavioural weight loss when the objective is to reduce binge eating.31 Behavioral management has also been successful in treating anorexia nervosa.32

Group therapy, support groups, and 12-step programs like Overeaters Anonymous may be useful as adjunctive treatment and for relapse prevention. Family therapy and marital therapy are helpful in cases of dysfunctional family patterns and interpersonal distress.

Maudsley Hospital developed a successful treatment that allows families to refeed patients at home. This manual based outpatient therapy has been particularly successful with shorter duration anorexia nervosa. Weight restoration and general stability make this an excellent option.33, 34, 35

Guided self-help manuals can reduce the number of binge–purge episodes in at least some patients with bulimia nervosa.36 In fact, a manual-driven self-help approach incorporating cognitive-behavioral principles combined with keeping contact with a general practice physician in one study did as well as specialist-based treatment in reducing bulimic episodes.37 Computer-based health education can improve knowledge and attitudes as a patient-friendly adjunct to therapy.

One unique approach is a behavioral family-based therapy for elementary school–age children with behavioral problems, disordered eating, and obesity. Children and parents were examined and tested before and after the intervention and all lost weight. Although eating disorders did not resolve, other behavioral problems did. There was less parental dissatisfaction as children developed better awareness and behavior patterns.38

Higher self-directedness at baseline is a good predictor of improvement at the end of a variety of interventions, as well as follow-up 6 to 12 months later. This might help explain why manual-driven self-help and psychoeducational programs that emphasize improvement of self-esteem and reassessment of body image have achieved some success.

Medication

Anorexia Nervosa

When there is no psychiatric comorbidity like depression, the evidence for significant efficacy is lacking, with very few methodologically sound studies.2, 29, 39 Although medication is less successful in anorexia nervosa than in bulimia nervosa, it is most often used in anorexia nervosa after weight has been restored but may begin earlier when indicated. Medication helps maintain weight and normal eating behavior and can treat associated psychiatric symptoms.40

Selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine) are commonly considered for patients with anorexia nervosa who have depressive, obsessive, or compulsive symptoms that persist in spite of or in the absence of weight gain. Tricyclic antidepressants are also effective in treating eating disorders. However, they should be used with caution, because they have greater risks of cardiac complications, including arrhythmias and hypotension.

Low doses of antipsychotics may be used for marked agitation and psychotic thinking, but they can frighten patients by increasing appetite dramatically, particularly if the patient is not psychotic. Antianxiety medications, such as benzodiazepines, may be used for extreme anticipatory anxiety concerning eating.

Estrogen replacement alone does not generally appear to reverse osteoporosis or osteopenia, and unless there is weight gain, it does not prevent further bone loss. There is very limited evidence of bisphosphonate’s efficacy in treating associated osteoporosis.

Promotility agents such as metoclopramide are commonly used for bloating and abdominal pains due to gastroparesis and premature satiety, but they require monitoring for drug-related extrapyramidal side effects.

Recombinant human growth hormone has helped stabilize patients medically in shorter hospital stays.

Bulimia Nervosa

Antidepressants are used primarily to reduce the frequency of disturbed eating and treat comorbid depression, anxiety, obsessions, and certain impulse-disorder symptoms. Medication can reduce binge episodes, but is not sufficient to be the sole treatment. The only medication approved by the U.S. Food and Drug Administration for bulimia nervosa is the SSRI fluoxetine (Prozac). Several studies have demonstrated efficacy of other SSRIs including sertraline (Zoloft), paroxetine (Paxil), and citalopram (Celexa); tricyclic antidepressants including imipramine (Tofranil), nortryptyline (Pamelor), and desipramine (Norpramin); and monoamine oxidase inhibitors (MAOIs) including tranylcypromine (Parnate). Doses of tricyclic antidepressants and MAOIs parallel those used to treat depression, but higher doses of fluoxetine (up to 80 mg/day) may be needed to treat bulimia nervosa, possibly by reducing an obsessive compulsive component of this disorder. Bupropion (Wellbutrin) has been associated with seizures in purging bulimic patients and its use is not recommended.

Other psychotropic drugs are sometimes used. Lithium continues to be used occasionally as an adjunct for comorbid disorders. Various anticonvulsants have successfully reduced binge eating for some patients, but they can also increase appetite. Topiramate lowers appetite but has been associated with cognitive side effects. Sibutramine has also been used to reduce appetite in bulimia nervosa and binge-eating disorder.41

Back to Top

Screening and Prevention

Prevention programs presented in schools to both genders or through organizations like the Girl Scouts have been successful in reducing risk factors for eating disorders. Often focusing on media literacy and interactive discussion, there are increasing reports of short-term and longer-term benefits in body satisfaction and acceptance of normal growth.38

Back to Top

Summary

  • The lifetime prevalence of anorexia and bulimia combined may be as high as 5% or more of the general population.
  • Bulimia nervosa is more common than anorexia nervosa and has a better prognosis.
  • The rate of mood, anxiety, and substance use disorders is higher in the families of bulimic than anorectic patients.
  • Hospitalization is indicated when body weight drops below 75% of ideal body weight, in the presence of significant fluid and electrolyte imbalance, and when heart rate falls below 40 bpm or rises above 110 bpm when the patient stands.
  • Antidepressant medication is more effective for bulimia nervosa than for anorexia nervosa.
  • Anorexia nervosa and bulimia nervosa respond well to a combination of individual, family, and group psychotherapy interventions that focus on the recovery of normal eating behavior.

Back to Top

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, text rev. Washington, DC: American Psychiatric Association, 2000.
  2. Devlin M, Jahraus J, DiMarco I. Eating disorders. In J Levenson (ed): Textbook of Psychosomatic Medicine. Second edit. Washington, DC: American Psychiatric Association, 2010, pp 305-333.
  3. Thomas JJ, Vartanian LR, Brownell KD: The relationship between eating disorder not otherwise specified (EDNOS) and officially recognized eating disorders: meta-analysis and implications for DSM. Psychol Bull. 2009, 135:407-433.
  4. Fairburn C, Harrison PJ, Brownell K: Eating disorders. Lancet. 2003, 361:407-416.
  5. Forman S, Middleman AB, Solomon D. Eating disorders: Epidemiology, pathogenesis, and clinical features. 2010, www.uptodate.com
  6. Keski R, 2008 American Psychiatric Association: Eating disorders measures. In Ameri¬can Psychiatric Association: Handbook of Psychiatric Measures. Wash¬ington, DC: American Psychiatric Association, 2009
  7. Hudson American Psychiatric Association Work Group on Eating Disorders: Practice guideline for the treatment of patients with eating disorders. 2006, 163(1 Suppl):1:1.
  8. Lee S, Ng KL, Kwok K, et al. The changing profile of eating disor¬ders at a tertiary psychiatric clinic in Hong Kong (1987- 2007). Int J Eat Disord. 2010, 43:307-314
  9. Hebebrand J, Hinney A. Environmental and genetic risk factors in obesity. Child Adolesc Psychiatric Clin N Am. 2009, 18:83-94.
  10. Mazzeo SE, Bulik CM. Environmental and genetic risk actors for eating disorders: what the clinician needs to know. Child Adoles Psychiatric Clin N Am. 2009, 18:67-82.
  11. Monteleone P, Maj M. Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions. Pharmacogenomics 2008, 9:1487-1520.
  12. Treasure JJ. Getting beneath the phenotype of anorexia nervosa: the search for viable endophenotypes and genotypes. Can J Psychiatry, 2007, 52:212-219.
  13. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nature Neurosci. 2005, 8:555-560.
  14. Davis C, Curtis C, Levitan RD, Carter JC, Kaplan AS, Kennedy JL. Appetite. 2011 Sep 3;57(3);711-717.
  15. Papadopoulos FC, Ekborn A, Brandt L, et al. Excess mortality causes of death and prognostic factors in anorexia nervosa. Br J Psychiatry. 2009, 194:10-17.
  16. American Psychiatric Association. Eating disorders measures. American Psychiatric Association: Handbook of Psychiatric Measures. Washington, DC: American Psychiatric Association, 2000, pp 647-673.
  17. Root TL, Pinheiro AP, Thornton L, et al. Substance use disorders in women with anorexia nervosa. Int J Eat Disord. 2010, 43:14-21.
  18. Herpertz-Dahlmann. Adolescent eating disorders: definitions, symptomatology, Epidemiology and comorbidity. Child Adolesc Psychiatry Clin N Am. 2009, 18:31-47.
  19. Guh DP, Bansback N, Amarsi Z, et al. The incidence of co-mor¬bidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009, 9:88.
  20. Schelbert KB. Comorbidities of obesity. Prim Care. 2009, 36:271-285.
  21. Takii M, Uchigata Y,Tokunaga S, et al. The duration of severe insulin omission is the factor most closely associated with the microvascular complications of type 1 diabetic females with clinical eating disorders. Int J Eat Disord. 2008, 41:259-264.
  22. Ostuzzi R, D’Andrea G, Francesconi F, et al. Eating disorders and headache: coincidence or consequence? Neurol SCi. 2008, 29:583-587.
  23. Natayanan V, Gaudiani JL, Harris RH, et al. Liver function test abnormalities in anorexia nervosa – cause or effect. Int J Eat Disord. 2010, 43:378-381.
  24. Kaplan AS, Noble S. Medical complications of eating disorders in Annual review of Eating Disorders Part 1-2007. Edited by Wonderlich 5, Mitchell JE, de Zwaan M, et al. Oxford, England, Radcliffe Publishing, 2007, 101-112.
  25. Micali N, Simonoff E, Treasure J. Risk of major adverse perinatal outcomes in women with eating disorders. Br J Psychiatry. 2007, 190:255-2599.
  26. Favaro A, Tenconi E, Santonastaso P. The relationship between obstetric complications and temperament in eating disorders: a mediation hypothesis. Psychosom Med. 2008, 70-372-377.
  27. Lesinskiene S, Barkus A, Ranceva N, et al. A meta-analysis of heart rate and QT interval alteration in anorexia nervosa. World J Biol Psychiatry. 2008, 9:86-91.
  28. Mehler PS, MacKenzie TD. Treatment of osteopenia and osteoporosis in anorexia nervosa: a systematic review of the literature. Int J Eat Disord. 2009, 42:195-201.
  29. American Psychiatric Association Work Group on Eating Disorders. Practice guidelines for the treatment of patients with eating disorders. Am J Psychiatry. 2006; 163 Suppl 1:1
  30. Fairburn CG, Cooper Z, Doll HA, et al. Transdiagnostic cognitive-behavioral therapy for patients with eating disorders two site trial with 60-week follow-up. Am J Psychiatry. 2009, 166:311-319.
  31. Wilson GT, Wilfey DE, Agras WS, et al. Psychological treatments of binge eating disorder: Arch Gen Psychiatry. 2010, 67:94-101.
  32. Attia E, Walsh BT. Behavioral management for anorexia nervosa. N Engl J Med. 2009, 360:500-506.
  33. Lock J, le Grange D, Agras WS, et al. Treatment Manual for An¬orexia Nervosa: a Family Based Approach. 2001, New York, Guilford.
  34. Le Grange D, Crosby RD, Rathouz PJ, et al. A randomized controlled comparison of family based treatment and supportive. psychotherapy for adolescent bulimia nervosa. Arch Gen Psychiatry. 2007, 64: 1049-1056.
  35. Eisler I, Simic M, Russell GF, et al. A randomized controlled treatment trial of two Forms of family therapy in adolescent anorexia nervosa: a five-year follow-up. J Child Psychol Psychiatry. 2007, 48:552-560.
  36. Bailer V, de Zwaan M, Leisch F, et al. Guided self-help versus cognitive-behavioral group therapy in the treatment of bulimia nervosa. Int J Eating Disorders. 2004, 35:522-537.
  37. Durand M, King M. Specialist treatment versus self-help for bulimia nervosa: A randomized, controlled trial in general practice. Br J Gen Prac. 2003, 53:371-377.
  38. Wade TD, Davidson S, O’Dea JA. A preliminary controlled evaluation of a school-based media literacy program and self-esteem program for reducing eating disorder risk factors. Int J Eating Disorders. 2003, 33:371.
  39. Claudino AM, Hay P, Lima MS, et al. Antidepressants for anorexia nervosa. Cochrane Database Syst Rev. 2006, (1):CD004365.
  40. Crow SJ, Mitchell JE, Roerig JD, et al. What potential role is there for medication treatment in anorexia nervosa? Int J Eat Disord. 2009, 42:1-8.
  41. Wilfey DE, Crow SJ, Hudson JI, et al. Efficacy of sibutramine for the treatment of binge eating distorder: a randomized multicenter placebo-controlled double-blind study. Am J Psychiatry. 2008, 165:51-58.

Back to Top